Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa.
MESA+Institute for Nanotechnology, University of Twente, Enschede 7500AE, The Netherlands; MyLife Technologies BV, Enschede 7500AE, The Netherlands; Department of Mechanical Engineering, Microsystems Group and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven 5600MB, The Netherlands.
J Control Release. 2014 Jul 10;185:130-8. doi: 10.1016/j.jconrel.2014.04.052. Epub 2014 May 5.
The transdermal route is an excellent site for drug delivery due to the avoidance of gastric degradation and hepatic metabolism, in addition to easy accessibility. Although offering numerous attractive advantages, many available transdermal systems are not able to deliver drugs and other compounds as desired. The use of hypodermic needles, associated with phobia, pain and accidental needle-sticks has been used to overcome the delivery limitation of macromolecular compounds. The means to overcome the disadvantages of hypodermic needles has led to the development of microneedles for transdermal delivery. However, since the initial stages of microneedle fabrication, recent research has been conducted integrating various fabrication techniques for generating sophisticated microneedle devices for transdermal delivery including progress on their commercialization. A concerted effort has been made within this review to highlight the current advances of microneedles, and to provide an update of pharmaceutical research in the field of microneedle-assisted transdermal drug delivery systems.
经皮给药途径是一种优秀的药物传递途径,因为它可以避免胃降解和肝代谢,并且易于接近。尽管具有许多吸引人的优点,但许多现有的经皮系统无法按预期输送药物和其他化合物。皮下注射针的使用,与恐惧症、疼痛和意外针刺有关,已被用于克服大分子化合物的输送限制。为了克服皮下注射针的缺点,已经开发出用于经皮给药的微针。然而,自从微针制造的初始阶段以来,最近的研究已经结合了各种制造技术来制造用于经皮给药的复杂微针装置,包括它们在商业化方面的进展。在这篇综述中,我们努力强调微针的最新进展,并提供微针辅助经皮药物输送系统领域的药物研究的最新情况。
J Control Release. 2014-5-5
J Pharm Pharmacol. 2011-11-4
Drug Dev Ind Pharm. 2012-4-23
Int J Pharm. 2008-12-8
Expert Opin Drug Deliv. 2007-1
Eur J Pharm Biopharm. 2019-1-8
Adv Drug Deliv Rev. 2004-3-27
J Drug Target. 2017-1
IEEE Trans Biomed Eng. 2007-5
J Nanobiotechnology. 2025-8-21
Adv Drug Deliv Rev. 2025-5
Biomed Eng Lett. 2024-3-29
ACS Sens. 2024-5-24